Hepatic Malignant Neoplasm Primary Non-Resectable
1 clinical trials · Condition
◉ Watch Hepatic Malignant Neoplasm Primary Non-Resectable
| Record | Firm | Date |
|---|---|---|
| Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy (NCT03266042) | Delcath Systems Inc. | 2016-01-14 |
Track Hepatic Malignant Neoplasm Primary Non-Resectable automatically
Every clearance here is in the API, with alerts when new ones post.